Profit taking weighs down Proteostasis Therapeutics By: MarketMinute.com Stock News December 18, 2017 at 16:32 PM EST Profit taking weighed down shares of Proteostasis Therapeutics Inc. (Nasdaq: PTI) 52 cents to close at $4.47. Related Stocks: Proteostasis Ther